Bachiller A, Lubeiro A, Diez A, Suazo V, Dominguez C, Blanco JA, Ayuso M, Hornero R, Poza J, Molina V (2014) Decreased entropy modulation of EEG response to novelty and relevance in schizophrenia during a P300 task. Eur Arch Psychiatry Clin Neurosci. https://doi.org/10.1007/s00406-014-0525-5
Cea-Canas B, Gomez-Pilar J, Nunez P, Rodriguez-Vazquez E, de Uribe N, Diez A, Perez-Escudero A, Molina V (2020) Connectivity strength of the EEG functional network in schizophrenia and bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 98:109801
Article CAS PubMed Google Scholar
Dehaene S, Kerszberg M, Changeux JP (1998) A neuronal model of a global workspace in effortful cognitive tasks. Proc Natl Acad Sci U S A 95(24):14529–14534
Article CAS PubMed PubMed Central Google Scholar
Di Forti M, Quattrone D, Freeman TP, Tripoli G, Gayer-Anderson C, Quigley H, Rodriguez V, Jongsma HE, Ferraro L, La Cascia C, La Barbera D, Tarricone I, Berardi D, Szoke A, Arango C, Tortelli A, Velthorst E, Bernardo M, Del-Ben CM, Menezes PR, Selten JP, Jones PB, Kirkbride JB, Rutten BP, de Haan L, Sham PC, van Os J, Lewis CM, Lynskey M, Morgan C, Murray RM, Group, E-G.W (2019) The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. Lancet Psychiatry 6(5):427–436
Diez A, Gomez-Pilar J, Poza J, Beno-Ruiz-de-la-Sierra R, Fernandez-Linsenbarth I, Recio-Barbero M, Nunez P, Holgado-Madera P, Molina V (2024) Functional network properties in schizophrenia and bipolar disorder assessed with high-density electroencephalography. Prog Neuropsychopharmacol Biol Psychiatry 129:110902
Article CAS PubMed Google Scholar
Diez A, Suazo V, Casado P, Martin-Loeches M, Molina V (2013) Spatial distribution and cognitive correlates of gamma noise power in schizophrenia. Psychol Med 43(6):1175–1186
Article CAS PubMed Google Scholar
Duff BJ, Macritchie KA, Moorhead TW, Lawrie SM, Blackwood DH (2013) Human brain imaging studies of DISC1 in schizophrenia, bipolar disorder and depression: a systematic review. Schizophr Res 147(1):1–13
Farkas I, Kallo I, Deli L, Vida B, Hrabovszky E, Fekete C, Moenter SM, Watanabe M, Liposits Z (2010) Retrograde endocannabinoid signaling reduces GABAergic synaptic transmission to gonadotropin-releasing hormone neurons. Endocrinology 151(12):5818–5829
Article CAS PubMed PubMed Central Google Scholar
Gomez-Pilar J, de Luis-Garcia R, Lubeiro A, de Uribe N, Poza J, Nunez P, Ayuso M, Hornero R, Molina V (2018) Deficits of entropy modulation in schizophrenia are predicted by functional connectivity strength in the theta band and structural clustering. Neuroimage Clin 18:382–389
Article PubMed PubMed Central Google Scholar
Gonzalez-Burgos G, Lewis DA (2012) NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia. Schizophr Bull 38(5):950–957
Article PubMed PubMed Central Google Scholar
Kay SR, Fiszbein A, Opler LA (1987) The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 13(2):261–276
Article CAS PubMed Google Scholar
Keefe RS, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L (2004) The brief assessment of cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res 68(2–3):283–297
Kirkpatrick B, Strauss GP, Nguyen L, Fischer BA, Daniel DG, Cienfuegos A, Marder SR (2011) The brief negative symptom scale: psychometric properties. Schizophr Bull 37(2):300–305
Kuepper R, Ceccarini J, Lataster J, van Os J, van Kroonenburgh M, van Gerven JM, Marcelis M, Van Laere K, Henquet C (2013) Delta-9-tetrahydrocannabinol-induced dopamine release as a function of psychosis risk: 18F-fallypride positron emission tomography study. PLoS One 8(7):e70378
Article CAS PubMed PubMed Central Google Scholar
Manoach DS (2003) Prefrontal cortex dysfunction during working memory performance in schizophrenia: reconciling discrepant findings. Schizophr Res 60(2–3):285–298
McLoughlin BC, Pushpa-Rajah JA, Gillies D, Rathbone J, Variend H, Kalakouti E, Kyprianou K (2014) Cannabis and schizophrenia. Cochrane Database Syst Rev. https://doi.org/10.1002/14651858.CD004837.pub3
Article PubMed PubMed Central Google Scholar
Metzner C, Maki-Marttunen T, Karni G, McMahon-Cole H, Steuber V (2022) The effect of alterations of schizophrenia-associated genes on gamma band oscillations. Schizophrenia (Heidelb) 8(1):46
Article CAS PubMed Google Scholar
Miller AP, Baranger DAA, Paul SE, Garavan H, Mackey S, Tapert SF, LeBlanc KH, Agrawal A, Bogdan R (2024) Neuroanatomical variability associated with early substance use initiation: results from the ABCD Study. medRxiv
Molina V, Bachiller A, Gomez-Pilar J, Lubeiro A, Hornero R, Cea-Canas B, Valcarcel C, Haidar MK, Poza J (2018) Deficit of entropy modulation of the EEG in schizophrenia associated to cognitive performance and symptoms. A replication study. Schizophr Res 195:334–342
Molina V, Lubeiro A, de Luis Garcia R, Gomez-Pilar J, Martin-Santiago O, Iglesias-Tejedor M, Holgado-Madera P, Segarra-Echeverria R, Recio-Barbero M, Nunez P, Haidar MK, Fernandez-Sevillano J, Sanz-Fuentenebro J (2020) Deficits of entropy modulation of the EEG: a biomarker for altered function in schizophrenia and bipolar disorder? J Psychiatry Neurosci 45(3):190032
Reddy-Thootkur M, Kraguljac NV, Lahti AC (2022) The role of glutamate and GABA in cognitive dysfunction in schizophrenia and mood disorders - a systematic review of magnetic resonance spectroscopy studies. Schizophr Res 249:74–84
Article CAS PubMed Google Scholar
Rentzsch J, Stadtmann A, Montag C, Kunte H, Plockl D, Hellweg R, Gallinat J, Kronenberg G, Jockers-Scherubl MC (2016) Attentional dysfunction in abstinent long-term cannabis users with and without schizophrenia. Eur Arch Psychiatry Clin Neurosci 266(5):409–421
Sherif M, Radhakrishnan R, D’Souza DC, Ranganathan M (2016) Human laboratory studies on cannabinoids and psychosis. Biol Psychiatry 79(7):526–538
Article CAS PubMed Google Scholar
Sherif MA, Cortes-Briones JA, Ranganathan M, Skosnik PD (2018) Cannabinoid-glutamate interactions and neural oscillations: implications for psychosis. Eur J Neurosci 48(8):2890–2902
Skosnik PD, D’Souza DC, Steinmetz AB, Edwards CR, Vollmer JM, Hetrick WP, O’Donnell BF (2012) The effect of chronic cannabinoids on broadband EEG neural oscillations in humans. Neuropsychopharmacology 37(10):2184–2193
Article CAS PubMed PubMed Central Google Scholar
Sun Y, Farzan F, Barr MS, Kirihara K, Fitzgerald PB, Light GA, Daskalakis ZJ (2011) gamma oscillations in schizophrenia: mechanisms and clinical significance. Brain Res 1413:98–114
Article CAS PubMed Google Scholar
Tandon R, Nasrallah H, Akbarian S, Carpenter WT Jr, DeLisi LE, Gaebel W, Green MF, Gur RE, Heckers S, Kane JM, Malaspina D, Meyer-Lindenberg A, Murray R, Owen M, Smoller JW, Yassin W, Keshavan M (2024) The schizophrenia syndrome, circa 2024: What we know and how that informs its nature. Schizophr Res 264:1–28
Vahed N, Saberizafarghandi MB, Bashirpour H, Ahmadkhaniha HR, Arezoomandan R (2024) Effect of cannabis on brain activity in males: quantitative electroencephalography and its relationship with duration, dosage, and age of onset. J Clin Neurosci 132:110982
Comments (0)